Is Former CStone Chairman the Medicine Ailing Hengrui Needs?
Hengrui Medicine started the New Year by naming CStone’s previous top official Jiang Ningjun as its new vice general manager and chief strategy officer.Key Takeaways:Hengrui Pharma has named the former…
Recent Articles
RELATED ARTICLES
-
CStone breaks up with drugs partner as U.S. rollout stalls
2616.HK
-
Stock disconnect triggers investor exodus from CStone Pharma
2616.HK
-
BeiGene goes for global growth with sales and R&D push
BGNE.US 6160.HK
-
Junshi hopes new scientist CEO can cure its woes
1877.HK 688180.SHG
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
FAST NEWS: CStone drug approved for treatment of advanced non-small cell lung cancer
2616.HK
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK
Discover hidden China stock gems in our weekly newsletter